AVAILS MEDICAL

Developing rapid digital detection of infections and treatment optimization

THE FUTURE OF DIAGNOSTICS

Accurate, rapid, digital detection of infections in any bodily fluid to indicate in real-time which drugs will be most effective at the point-of-prescription.

OUTLOOK

Today the US spends $20B+ on infection detection. The market for efficient bacteria resistance detection has enormous potential. Avails Medical is pioneering the current diagnostics market with a groundbreaking technology that targets this global health threat.

Avails Medicals’ cost-effective platform will transform the diagnostics market by enabling for the first time diagnostic-guided therapy at the point-of-care, reducing time-to-treatment from days to minutes.

EXAMPLE MARKETS IN NEED FOR RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING (AST)

INFECTIONS

Urinary Tract Infection

Sepsis

Sexual Transmitted Diseases

MRSA

Meningitis

Pharyngitis

Avails Medical is being developed to allow for immediate detection of pathogens and proper treatment

The platform is being designed to increase efficiency and save the time of incorrect diagnosis